Chang David D
SEC CIK 1611024 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | Pres, CEO, Dir | 5.15M | — | $639.1K | 11 | 2022-03-15 | 2026-03-16 |
Most active insiders at ALLO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chang David D | Pres, CEO, Dir | — | $289.5K |
| 2 | Roberts Zachary | EVP of R, D | — | $104.2K |
| 3 | Douglas Earl Martin | SVP, GC | — | $103.3K |
| 4 | Parker Geoffrey M. | CFO | — | $88.5K |
| 5 | Beneski Benjamin Machinas | SVP, Chief Technical Off | — | $51.7K |
| 6 | Yoshiyama Annie | SVP, Fin | — | $29.3K |
| 7 | Kazam Joshua A | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-18 | 2026-03-16 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO, Dir | S - Sale | $2.47 | -47.8K | 5.15M | -0.9% | -$118.0K | |
| D | 2026-02-04 | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO, Dir | S - Sale | $1.80 | -95.3K | 5.19M | -2% | -$171.5K |
| 2025-03-18 | 2025-03-14 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO, Dir | S - Sale | $1.96 | -46.7K | 5.28M | -0.9% | -$91.5K | |
| 2025-02-05 | 2025-02-03 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO, Dir | S - Sale | $1.68 | -46.0K | 5.32M | -0.9% | -$77.3K | |
| D | 2025-01-28 | 2025-01-24 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO, Dir | A - Grant | $0.00 | +552.2K | 5.36M | +11% | $0 |
| 2024-05-20 | 2024-05-16 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO, Dir | A - Grant | $2.90 | +344.8K | 4.81M | +8% | +$1.00M | |
| 2024-03-18 | 2024-03-14 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO, Dir | F - Tax | $4.33 | -53.4K | 4.47M | -1% | -$231.2K | |
| D | 2024-01-31 | 2024-01-25 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO, Dir | A - Grant | $0.00 | +317.8K | 4.51M | +8% | $0 |
| D | 2023-03-24 | 2023-03-22 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO, Dir | A - Grant | $0.00 | +1.92M | 4.19M | +85% | $0 |
| 2023-03-16 | 2023-03-14 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO, Dir | F - Tax | $5.56 | -22.3K | 2.27M | -1.0% | -$124.2K | |
| 2022-03-17 | 2022-03-15 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO, Dir | S - Sale | $7.65 | -23.6K | 2.29M | -1% | -$180.9K |
Purchase Sale Sale after option exercise All abbreviations